Key result
DOACs and LMWH were evaluated for efficacy and safety in cancer-associated thrombosis, but the provided abstract lacks the results of this systematic review and meta-analysis.
Key points are not available for this paper at this time.
Design
Systematic review and meta-analysis
Meta-analysis offers Level 1 evidence; leaves open applicability to cardiovascular practice pending targeted trials.
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2020) studied this question. DOACs and LMWH were evaluated for efficacy and safety in cancer-associated thrombosis, but the provided abstract lacks the results of this systematic review and meta-analysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: